BioLum Sciences Overview
- Founded
- 2014
- Status
- Private
- Employees
- 5
- Latest Deal Type
- Seed
- (Cancelled)
- Latest Deal Amount
- $1M
- Investors
- 5
BioLum Sciences General Information
Description
Developer of core analysis platform and chemiluminescent chemistry designed to specialize in bioanalytical chemistry & medical device development. The company uses advanced chemical systems to measure biomarkers in exhaled breath condensate and blood samples to treat chronic diseases such as asthma, chronic obstructive pulmonary disease (COPD), hypertension, and heart failure, with a blood analysis product that measures nitric oxide and nitrative stress metabolites in the blood using a simple finger-prick test thereby, providing physicians, researchers, and patients with a critical gauge of endothelial function and cardiovascular health.
Contact Information
Website
www.biolumsciences.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Decision/Risk Analysis
Diagnostic Equipment
Primary Office
- 3060 Pegasus Park Drive
- Building 6
- Dallas, TX 75247
- United States
BioLum Sciences Timeline
BioLum Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Seed Round | $1M | Cancelled | Generating Revenue | |||
| 7. Grant | 01-May-2020 | 00000 | 00000 | Completed | Generating Revenue | |
| 6. Angel (individual) | 00000 | 00000 | 000 | Completed | Startup | |
| 5. Accelerator/Incubator | 20-Sep-2019 | 000.00 | 00000 | Completed | Startup | |
| 4. Accelerator/Incubator | 01-Jul-2018 | 00000 | Completed | Startup | ||
| 3. Seed Round | 16-Jun-2017 | 00000 | 00000 | Completed | Startup | |
| 2. Grant | 06-Nov-2014 | $65K | $100K | Completed | Startup | |
| 1. Capitalization | 01-Jan-2014 | $100K | $100K | Completed | Startup |
BioLum Sciences Patents
BioLum Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210059560-A1 | Sensor devices and systems for monitoring markers in breath | Pending | 15-Mar-2018 | 000000000 |
BioLum Sciences Executive Team (4)
BioLum Sciences Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jonathan Crowder | Intelis Capital | Board Member | 000 0000 |
BioLum Sciences Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialBioLum Sciences Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| National Science Foundation | Government | 000 0000 | 000000 0 | ||
| G4A | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| Intelis Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Southern Methodist University Endowment | Limited Partner | 000 0000 | 000000 0 |